DRG 848

Medical DRG

Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC

TypeMedicalMDC17Dx Codes3

What is MS-DRG 848?

MS-DRG 848 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 17 (MDC 17) without a significant Complication or Comorbidity. It maps to 3 ICD-10-CM diagnosis codes. For FY 2026 it carries a relative weight of 0.8494 with a geometric mean length of stay of 2.6 days and an arithmetic mean of 3.3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
Linked Codes
3 diagnosis
Billable Dx
100%
3 of 3 shown

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
0.8494
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
2.6 days
Used for transfer payment calculations
Arithmetic Mean LOS
3.3 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
846Chemotherapy without Acute Leukemia as Secondary Diagnosis with MCC2.59255.8 days
847Chemotherapy without Acute Leukemia as Secondary Diagnosis with CC1.30823.8 days
848Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCCThis page0.84942.6 days

Linked ICD-10-CM Diagnosis Mappings

  • Z08

    Encounter for follow-up examination after completed treatment for malignant neoplasm

    BillableChapter 21
  • Z51.11

    Encounter for antineoplastic chemotherapy

    BillableChapter 21
  • Z51.12

    Encounter for antineoplastic immunotherapy

    BillableChapter 21